Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
2.
Transpl Int ; 20(4): 386-9, 2007 Apr.
Article in English | MEDLINE | ID: mdl-17326780

ABSTRACT

Hemolytic uremic syndrome (HUS) is a rare complication following solid organ transplantation. We report on a patient who underwent renal transplantation using Campath-1H induction and tacrolimus maintenance therapy who developed HUS, which was managed by plasma exchange and switch to Rapamycin. However, graft function could not be restored.


Subject(s)
Antibodies, Monoclonal/adverse effects , Antibodies, Neoplasm/adverse effects , Hemolytic-Uremic Syndrome/chemically induced , Immunosuppressive Agents/adverse effects , Kidney Transplantation/adverse effects , Adult , Alemtuzumab , Antibodies, Monoclonal, Humanized , Hemolytic-Uremic Syndrome/drug therapy , Humans , Male , Plasma Exchange , Sirolimus/therapeutic use , Tacrolimus/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL
...